Fil LTD Sanofi Transaction History

Fil LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$45.39 - $50.36 $6,944 - $7,705	153 Added 46.22%	484 $23,000
Q1 2024 May 13, 2024	BUY	$45.75 - $52.48 $1,738 - $1,994	38 Added 12.97%	331 $16,000
Q4 2023 Feb 13, 2024	BUY	$43.13 - $54.79 $2,975 - $3,780	69 Added 30.8%	293 $14,000
Q3 2023 Nov 13, 2023	BUY	$50.95 - $55.2 $458 - $496	9 Added 4.19%	224 $12,000
Q2 2023 Aug 11, 2023	BUY	$50.45 - $57.18 $4,288 - $4,860	85 Added 65.38%	215 $11,000
Q1 2023 May 11, 2023	BUY	$45.86 - $54.45 $4,861 - $5,771	106 Added 441.67%	130 $7,000
Q4 2022 Feb 13, 2023	BUY	$38.86 - $48.55 $505 - $631	13 Added 118.18%	24 $1,000
Q3 2022 Nov 10, 2022	BUY	$37.22 - $100.5 $409 - $1,105	11 New	11 $0

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.